单位：[1]China Acad Chinese Med Sci, Ctr Cardiovasc, Xiyuan Hosp, Beijing 100091, Peoples R China[2]Beijing Univ Chinese Med, Grad Sch, Beijing 100029, Peoples R China[3]China Japan Friendship Hosp, Natl Integrat Med Ctr Cardiovasc Dis, Beijing 100029, Peoples R China
Tanshinone IIA (Tan IIA) is a member of the major lipophilic components extracted from the root of Salvia miltiorrhiza Bunge, which is currently used in China and other neighboring countries to treat patients suffering from myocardial infarction (MI), angina pectoris, stroke, diabetes, sepsis, and other conditions. However, Tan IIA is not easy to be absorbed through intestinal pathway. To raise the bioavailability of the herb, sodium tanshinone IIA sulfonate (STS) was developed. This paper discussed the pharmacology of Tan IIA, STS, and their potential cardioprotective effects.
第一作者单位：[2]Beijing Univ Chinese Med, Grad Sch, Beijing 100029, Peoples R China[3]China Japan Friendship Hosp, Natl Integrat Med Ctr Cardiovasc Dis, Beijing 100029, Peoples R China
通讯作者：
推荐引用方式(GB/T 7714)：
Shang Qinghua,Xu Hao,Huang Li.Tanshinone IIA: A Promising Natural Cardioprotective Agent[J].EVIDENCE-BASED COMPLEMENTARY and ALTERNATIVE MEDICINE.2012,2012:doi:10.1155/2012/716459.
APA：
Shang, Qinghua,Xu, Hao&Huang, Li.(2012).Tanshinone IIA: A Promising Natural Cardioprotective Agent.EVIDENCE-BASED COMPLEMENTARY and ALTERNATIVE MEDICINE,2012,
MLA：
Shang, Qinghua,et al."Tanshinone IIA: A Promising Natural Cardioprotective Agent".EVIDENCE-BASED COMPLEMENTARY and ALTERNATIVE MEDICINE 2012.(2012)
